China

Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…

The number of credit cards in circulation and credit card current value transactions are expected to increase in 2023, mainly driven by further improvements in mobility and economic conditions after COVID-19 restrictions were lifted at the end of…

Shaped liquid cartons, already a major pack type within the category, were gaining share in dairy food packaging in China in 2023 due to their versatility, convenience and superior branding possibilities. These cartons are easy to handle, pour and…

Retail current value sales of dairy products and alternatives in China in 2024 are projected to continue the downwards trend observed in the previous year, with an anticipated decline in the mid-single digits, with retail volume sales also set to…

In 2023, debit card spending is expected to see year-on-year growth both in terms of payment transactions and payment values, derived from pent-up demand over the last three years, which has been released in this year. Many consumers have taken the…

In 2023, deodorants in China exhibited a modest recovery, after recording a decline in 2022 during the pandemic outbreaks, although sales did not return to the 2021 level. Leading players such as Nivea (Beiersdorf) and Unilever continued to face…

After a year of slight decline in 2022, depilatories showed current value growth in China in 2023, and rebounded to the 2021 level of sales, mainly due to the easing of pandemic restrictions and increasing consumer awareness. The relaxation of…

In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…

Dietary supplements is expected to register robust growth in China in 2023, after the easing of COVID-19-related restrictions. The surge in COVID-19 cases since the lifting of restrictions in late December 2022 brought health products such a dietary…

In 2023, the prevalence of the XBB strain of COVID-19 in China, which typically presents with gastrointestinal discomfort and diarrhoea symptoms, has led to the rising popularity of digestive remedies, with the overall category set to achieve high…